EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Intratumoral Immunotherapy with Cowpea Mosaic Virus and Interleukin-12 Eliminates Established Treated Tumors and Generates Robust Systemic Immunity to Suppress the Growth of Untreated Metastatic Tumors

Alex Misiaszek, Alicia M Santos, Greg W Ho, Jennifer Fields, Kevine Silihe Kamga, Radu Stan, Jessica F Affonso De Oliveira iD, Nicole F Steinmetz iD, Steven Fiering iD

Molecular Pharmaceutics · 2025

DOI: 10.1021/acs.molpharmaceut.4c01539 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2025. Verfasst von Alex Misiaszek und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, Dartmouth Geisel School of Medicine, Hanover, New Hampshire 03755, United States. Hauptthemen laut MEDLINE: Interleukin-12, Immunotherapy, Comovirus, Melanoma, Experimental. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NHLBI NIH HHS, National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Intratumoral immunotherapy (ITIT) delivers immune-stimulating agents or treatments directly into solid tumors to reverse the immunosuppressive nature of the tumor microenvironment (TME) and enables local and systemic antitumor immunity. However, optimal clinical strategies for ITIT are not yet fully understood. Cowpea mosaic virus (CPMV) is a plant virus that is not infectious in mammals but is a powerful multi-toll-like receptor (TLR) agonist which stimulates potent antitumor immunity when used in ITIT. ITIT by transfection of interleukin-12 (IL-12) expressing plasmids into melanoma tumors via in vivo electroporation is being assessed in Phase II clinical trials to treat metastatic disease. We investigated the combination of CPMV with IL-12 plasmid electroporation to generate systemic (abscopal) immunity superior to that from either monotherapy alone. Mice were inoculated with two B16-F10 melanoma or MC38 colorectal cancer tumors and one tumor on each flank. One tumor was treated once per week for 2 weeks with IL-12 electroporation and CPMV intratumoral injection. IL-12 electroporation following CPMV injection greatly reduced the efficacy of CPMV by disrupting its viral structure. Conversely, electroporation of IL-12 prior to CPMV injection led to total clearance of 100% of treated tumors and significantly greater suppression of distant, untreated tumors compared to either monotherapy or the reverse treatment order (CPMV IT injection, followed by IL-12 electroporation). This superior abscopal effect led to a significantly improved survival. Our novel treatment strategy offers significant translational value in treating solid tumors by improving the local and systemic efficacy of IL-12 electroporation or CPMV alone.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Interleukin-12ImmunotherapyComovirusMelanoma, ExperimentalColorectal NeoplasmsAnimalsMiceMice, Inbred C57BLElectroporationFemaleTumor MicroenvironmentCell Line, TumorPlasmids

Stichwörter der Autor:innen

IL-12cowpea mosaic viruselectroporationin vivo transfectionintratumoral immunotherapy

Substanzen

Interleukin-12

Autor:innen und Institutionen

  • Department of Microbiology and Immunology, Dartmouth Geisel School of Medicine, Hanover, New Hampshire 03755, United States.
  • Dartmouth Cancer Center, Dartmouth Geisel School of Medicine, Hanover, New Hampshire 03755, United States.
  • Department of Biochemistry and Cell Biology, Dartmouth Geisel School of Medicine, Hanover, New Hampshire 03755, United States.

ORCID-Profile: Jessica F Affonso De Oliveira, Nicole F Steinmetz, Steven Fiering

Förderung

  • NCI NIH HHS
  • NHLBI NIH HHS
  • National Cancer Institute

Zitieren

APA

Misiaszek, A., Santos, A. M., Ho, G. W., Fields, J., Kamga, K. S., Stan, R., Affonso De Oliveira, J. F., Steinmetz, N. F., & Fiering, S. (2025). Intratumoral Immunotherapy with Cowpea Mosaic Virus and Interleukin-12 Eliminates Established Treated Tumors and Generates Robust Systemic Immunity to Suppress the Growth of Untreated Metastatic Tumors. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.4c01539

Vancouver

Misiaszek A, Santos AM, Ho GW, Fields J, Kamga KS, Stan R, et al. Intratumoral Immunotherapy with Cowpea Mosaic Virus and Interleukin-12 Eliminates Established Treated Tumors and Generates Robust Systemic Immunity to Suppress the Growth of Untreated Metastatic Tumors. Molecular Pharmaceutics. 2025. doi:10.1021/acs.molpharmaceut.4c01539

BibTeX
@article{Misiaszek2025,
  author = {Misiaszek, Alex and Santos, Alicia M and Ho, Greg W and Fields, Jennifer and Kamga, Kevine Silihe and Stan, Radu and Affonso De Oliveira, Jessica F and Steinmetz, Nicole F and Fiering, Steven},
  title = {Intratumoral Immunotherapy with Cowpea Mosaic Virus and Interleukin-12 Eliminates Established Treated Tumors and Generates Robust Systemic Immunity to Suppress the Growth of Untreated Metastatic Tumors},
  journal = {Molecular Pharmaceutics},
  year = {2025},
  doi = {10.1021/acs.molpharmaceut.4c01539}
}
Kostenlos starten →